$335 Million is the total value of GRIMES & COMPANY, INC.'s 197 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 50.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
USB | U.S. Bancorp | $1,179,000 | +10.4% | 29,184 | 0.0% | 0.35% | -2.5% | |
BRKA | Berkshire Hathaway Inc. Cl A | $890,000 | +4.5% | 5 | 0.0% | 0.27% | -7.6% | |
D | Dominion Resources Inc. | $584,000 | +3.7% | 9,019 | 0.0% | 0.18% | -7.9% | |
IDXX | IDEXX Laboratories Inc. | $404,000 | +6.6% | 3,800 | 0.0% | 0.12% | -5.5% | |
BSFT | BroadSoft Inc. | $370,000 | -24.3% | 13,541 | 0.0% | 0.11% | -32.7% | |
EV | Eaton Vance Corp. | $359,000 | +9.8% | 8,400 | 0.0% | 0.11% | -3.6% | |
CHKP | Check Point Software Technolog | $274,000 | +14.2% | 4,250 | 0.0% | 0.08% | +1.2% | |
PCAR | PACCAR Inc | $273,000 | +6.2% | 4,622 | 0.0% | 0.08% | -5.7% | |
BIIB | Biogen IDEC Inc. | $269,000 | +15.9% | 963 | 0.0% | 0.08% | +2.6% | |
SAM | Boston Beer Company Inc. | $242,000 | -0.8% | 1,000 | 0.0% | 0.07% | -13.3% | |
BSX | Boston Scientific | $196,000 | +2.6% | 16,296 | 0.0% | 0.06% | -9.2% | |
STAA | STAAR Surgical Company | $166,000 | +19.4% | 10,265 | 0.0% | 0.05% | +6.4% | |
LVGAF | GLV Inc Cl A Sub Vtg | $94,000 | +13.3% | 25,000 | 0.0% | 0.03% | 0.0% | |
CRIS | Curis Inc. | $48,000 | -36.8% | 17,000 | 0.0% | 0.01% | -46.2% | |
IG | IGI Laboratories Inc. | $31,000 | +72.2% | 10,000 | 0.0% | 0.01% | +50.0% | |
AEMD | Aethlon Medical Inc. | $9,000 | +12.5% | 50,000 | 0.0% | 0.00% | 0.0% | |
Gerber Scientific Inc. Escrow | $0 | – | 10,000 | 0.0% | 0.00% | – | ||
FPXA | Fortune Nat Res Corp No Stockh | $0 | – | 18,000 | 0.0% | 0.00% | – | |
ILED | EvoLucia Inc. | $0 | – | 20,000 | 0.0% | 0.00% | – | |
USXP | Universal Express Inc | $0 | – | 32,000 | 0.0% | 0.00% | – | |
CRON | Cronus Corp. | $0 | – | 10,000 | 0.0% | 0.00% | – | |
WTCH | Wastech Inc | $0 | – | 21,600 | 0.0% | 0.00% | – | |
WGATQ | WorldGate Communications Inc. | $0 | – | 164,605 | 0.0% | 0.00% | – | |
Commonwealth REIT 100000thspref | $0 | – | 50,000 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-03
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
APPLE INC | 42 | Q3 2023 | 3.8% |
Microsoft Corporation | 42 | Q3 2023 | 2.7% |
Intel Corporation | 42 | Q3 2023 | 3.0% |
Cisco Systems, Inc. | 42 | Q3 2023 | 2.5% |
ACCENTURE PLC IRELAND | 42 | Q3 2023 | 2.1% |
QUALCOMM Incorporated | 42 | Q3 2023 | 1.7% |
UNITED PARCEL SERVICE INC | 42 | Q3 2023 | 1.8% |
NOVARTIS AG | 42 | Q3 2023 | 2.1% |
UNITEDHEALTH GROUP INC | 42 | Q3 2023 | 1.4% |
BOEING CO | 42 | Q3 2023 | 1.6% |
View GRIMES & COMPANY, INC.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-17 |
13F-HR | 2024-01-24 |
13F-HR | 2023-10-19 |
13F-HR | 2023-07-19 |
13F-HR | 2023-04-20 |
13F-HR | 2023-01-25 |
13F-HR | 2022-10-28 |
13F-HR | 2022-07-22 |
13F-HR | 2022-05-06 |
13F-HR | 2022-02-01 |
View GRIMES & COMPANY, INC.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.